- Home
- ORIC vs TBLA Comparison
ORIC vs TBLA Comparison
Compare ORIC & TBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- TBLA
- Stock Information
- Founded
- ORIC 2014
- TBLA 2007
- Country
- ORIC United States
- TBLA United States
- Employees
- ORIC N/A
- TBLA N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- TBLA Computer Software: Programming Data Processing
- Sector
- ORIC Health Care
- TBLA Technology
- Exchange
- ORIC Nasdaq
- TBLA Nasdaq
- Market Cap
- ORIC 1.1B
- TBLA 1.2B
- IPO Year
- ORIC 2020
- TBLA N/A
- Fundamental
- Price
- ORIC $11.54
- TBLA $3.98
- Analyst Decision
- ORIC Strong Buy
- TBLA Strong Buy
- Analyst Count
- ORIC 11
- TBLA 5
- Target Price
- ORIC $18.78
- TBLA $4.50
- AVG Volume (30 Days)
- ORIC 1.1M
- TBLA 3.0M
- Earning Date
- ORIC 11-13-2025
- TBLA 11-05-2025
- Dividend Yield
- ORIC N/A
- TBLA N/A
- EPS Growth
- ORIC N/A
- TBLA N/A
- EPS
- ORIC N/A
- TBLA 0.08
- Revenue
- ORIC N/A
- TBLA $1,880,771,000.00
- Revenue This Year
- ORIC N/A
- TBLA $8.31
- Revenue Next Year
- ORIC N/A
- TBLA $4.65
- P/E Ratio
- ORIC N/A
- TBLA $50.83
- Revenue Growth
- ORIC N/A
- TBLA 10.96
- 52 Week Low
- ORIC $3.90
- TBLA $2.50
- 52 Week High
- ORIC $14.93
- TBLA $4.30
- Technical
- Relative Strength Index (RSI)
- ORIC 40.39
- TBLA 62.16
- Support Level
- ORIC $11.28
- TBLA $3.86
- Resistance Level
- ORIC $12.50
- TBLA $4.05
- Average True Range (ATR)
- ORIC 0.82
- TBLA 0.17
- MACD
- ORIC -0.16
- TBLA -0.00
- Stochastic Oscillator
- ORIC 22.22
- TBLA 68.95
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About TBLA Taboola.com Ltd.
Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, United States, Germany, Rest of the world. It generates the majority of its revenue from the United States.